AAAAAA

   
Results: 1-9 |
Results: 9
A PHASE-II STUDY OF 13-CIS-RETINOIC ACID IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: BERG WJ SCHWARTZ LH AMSTERDAM A MAZUMDAR M VLAMIS V LAW TM NANUS DM MOTZER RJ
Citation: Wj. Berg et al., A PHASE-II STUDY OF 13-CIS-RETINOIC ACID IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 15(4), 1997, pp. 353-355
DESPITE DIFFERENT WALL COLORS, VERTICAL SCOTOPIC ILLUMINANCE PREDICTSPUPIL SIZE
Authors: BERMAN SM JEWETT DL BENSON BR LAW TM
Citation: Sm. Berman et al., DESPITE DIFFERENT WALL COLORS, VERTICAL SCOTOPIC ILLUMINANCE PREDICTSPUPIL SIZE, Journal of the Illuminating Engineering Society, 26(2), 1997, pp. 59
BREAST-CANCER IN ELDERLY WOMEN - PRESENTATION, SURVIVAL, AND TREATMENT OPTIONS
Authors: LAW TM HESKETH PJ PORTER KA LAWNTSAO L MCANAW R LOPEZ MJ
Citation: Tm. Law et al., BREAST-CANCER IN ELDERLY WOMEN - PRESENTATION, SURVIVAL, AND TREATMENT OPTIONS, The Surgical clinics of North America, 76(2), 1996, pp. 289
INTERFERON ALFA-2A AND 13-CIS-RETINOIC ACID IN RENAL-CELL CARCINOMA -ANTITUMOR-ACTIVITY IN A PHASE-II TRIAL AND INTERACTIONS IN-VITRO
Authors: MOTZER RJ SCHWARTZ L LAW TM MURPHY BA HOFFMAN AD ALBINO AP VLAMIS V NANUS DM
Citation: Rj. Motzer et al., INTERFERON ALFA-2A AND 13-CIS-RETINOIC ACID IN RENAL-CELL CARCINOMA -ANTITUMOR-ACTIVITY IN A PHASE-II TRIAL AND INTERACTIONS IN-VITRO, Journal of clinical oncology, 13(8), 1995, pp. 1950-1957
PHASE-III RANDOMIZED TRIAL OF INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: LAW TM MOTZER RJ MAZUMDAR M SELL KW WALTHER PJ OCONNELL M KHAN A VLAMIS V VOGELZANG NJ BAJORIN DF
Citation: Tm. Law et al., PHASE-III RANDOMIZED TRIAL OF INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Cancer, 76(5), 1995, pp. 824-832
PHASE-II TRIAL OF LIPOSOMAL ENCAPSULATED DOXORUBICIN IN PATIENTS WITHADVANCED RENAL-CELL CARCINOMA
Authors: LAW TM MENCEL P MOTZER RJ
Citation: Tm. Law et al., PHASE-II TRIAL OF LIPOSOMAL ENCAPSULATED DOXORUBICIN IN PATIENTS WITHADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 12(4), 1994, pp. 323-325
PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: LAW TM ILSON DH MOTZER RJ
Citation: Tm. Law et al., PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 12(2), 1994, pp. 143-145
THE MANAGEMENT OF PATIENTS WITH ADVANCED GERM-CELL TUMORS - SEMINOMA AND NONSEMINOMA
Authors: LAW TM MOTZER RJ BAJORIN DF BOSL GJ
Citation: Tm. Law et al., THE MANAGEMENT OF PATIENTS WITH ADVANCED GERM-CELL TUMORS - SEMINOMA AND NONSEMINOMA, Urologic clinics of North America, 21(4), 1994, pp. 773-783
PROBLEMS AND PERCEPTIONS
Authors: WEBSTER AJ LIGHTFOOT WP VAZQUEZ M HEPNER PJ KAPLAN GC LAU S MIKKANEN AQ LAW TM
Citation: Aj. Webster et al., PROBLEMS AND PERCEPTIONS, Trial, 29(8), 1993, pp. 52-65
Risultati: 1-9 |